Page last updated: 2024-10-22

amitriptyline and Laryngeal Neoplasms

amitriptyline has been researched along with Laryngeal Neoplasms in 1 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Laryngeal Neoplasms: Cancers or tumors of the LARYNX or any of its parts: the GLOTTIS; EPIGLOTTIS; LARYNGEAL CARTILAGES; LARYNGEAL MUSCLES; and VOCAL CORDS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Murphy, GE1
Ogura, J1

Other Studies

1 other study available for amitriptyline and Laryngeal Neoplasms

ArticleYear
Rehabilitation following laryngectomy.
    Geriatrics, 1967, Volume: 22, Issue:12

    Topics: Amitriptyline; Depression; Electroconvulsive Therapy; Humans; Imipramine; Laryngeal Neoplasms; Laryn

1967